Which of these protein targets will have at least one new drug targeting them receive FDA approval between 2025 and 2030
Plus
5
Ṁ11252030
74%
GLP-1R
46%
PCSK9
39%
BTK
39%
CDK4/6
39%
KRAS G12C
39%
TSLP
39%
IL-23
39%
Factor XIa
39%
JAK1
39%
PI3K delta
39%
SYK
39%
TYK2
39%
IL-1R
39%
CD47
39%
BCL-2
39%
SARM1
31%
CDK7
31%
RIPK1
31%
IL-33
31%
CD19
A valid FDA approval under this prediction market must have occurred between January 1, 2025 and December 31, 2029. The approval must be for a novel drug (new molecular entity or new biological product) where the specified protein is explicitly listed as the primary target in the FDA approval documentation. New formulations, biosimilars, and combination products of previously approved drugs do not qualify. Verification will be conducted using the official FDA drugs database (drugs@FDA) as the authoritative source. In cases where a drug has multiple mechanisms of action, the protein must be identified as the primary, not secondary, target.
This question is managed and resolved by Manifold.
Get
1,000
and3.00
Related questions
Related questions
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
54% chance
💊Will FDA approve 50 or more novel drugs in 2024?
84% chance
The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
24% chance
Which applications of CRISPR technology will achieve regulatory approval for use in humans by 2030?
Will a drug designed with significant contribution from an AlphaFold-like system pass a Phase I trial by end of 2025?
33% chance
Will a vaccine for HIV be approved by the FDA by 2030?
67% chance
Will an AI-designed drug get FDA approval by the end of 2025?
30% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
66% chance
💊Will INS018_055 be FDA-approved by 2030?
48% chance
Will FDA approve more than 10 new mRNA based vaccines before 2030?
77% chance